 | • レポートコード：QAF27814 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の経口ワクチン市場について種類別（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他）、用途別（公共用、個人用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・経口ワクチン市場の概要 ・世界の主要地域別経口ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の経口ワクチン市場規模2016-2021：種類別（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他） ・世界の経口ワクチン市場予測2012-2027：種類別（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他） ・世界の経口ワクチン市場規模2016-2021：用途別（公共用、個人用） ・世界の経口ワクチン市場予測2012-2027：用途別（公共用、個人用） ・経口ワクチンのアメリカ市場規模と予測2016-2021 ・経口ワクチンのヨーロッパ市場規模と予測2016-2021 ・経口ワクチンの中国市場規模と予測2016-2021 ・経口ワクチンの日本市場規模と予測2016-2021 ・経口ワクチンの東南アジア市場規模と予測2016-2021 ・経口ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、GSK、Sanofi、Lanzhou Institute、Serum Institute、Valneva、Shanghai United Cell、Bibcol、PaxVax、Vabiotech、Tiantan Biological、EuBiologics、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals） ・経口ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・経口ワクチンの市場動向・機会・課題 ・調査の結論 |
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Market Analysis and Insights: Global Oral Vaccines Market
The global Oral Vaccines market was valued at US$ 2679.1 in 2020 and will reach US$ 4043.1 million by the end of 2027, growing at a CAGR of 7.1% during 2022-2027.
Global Oral Vaccines Scope and Market Size
The global Oral Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Segment by Application
Public
Private
The Oral Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Oral Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1 Oral Vaccines Market Overview
1.1 Oral Vaccines Product Scope
1.2 Oral Vaccines Segment by Type
1.2.1 Global Oral Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.2.5 Others
1.3 Oral Vaccines Segment by Application
1.3.1 Global Oral Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Public
1.3.3 Private
1.4 Oral Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Oral Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Oral Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Oral Vaccines Price Trends (2016-2027)
2 Oral Vaccines Estimates and Forecasts by Region
2.1 Global Oral Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Oral Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Oral Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Oral Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Oral Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Oral Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Oral Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Oral Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Oral Vaccines Estimates and Projections (2016-2027)
2.4.3 China Oral Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Oral Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Oral Vaccines Estimates and Projections (2016-2027)
2.4.6 India Oral Vaccines Estimates and Projections (2016-2027)
3 Global Oral Vaccines Competition Landscape by Players
3.1 Global Top Oral Vaccines Players by Sales (2016-2021)
3.2 Global Top Oral Vaccines Players by Revenue (2016-2021)
3.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Vaccines as of 2020)
3.4 Global Oral Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Oral Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Oral Vaccines Market Size by Type
4.1 Global Oral Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Oral Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Oral Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Oral Vaccines Price by Type (2016-2021)
4.2 Global Oral Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Oral Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Oral Vaccines Price Forecast by Type (2022-2027)
5 Global Oral Vaccines Market Size by Application
5.1 Global Oral Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Oral Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Oral Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Oral Vaccines Price by Application (2016-2021)
5.2 Global Oral Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Oral Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Oral Vaccines Price Forecast by Application (2022-2027)
6 North America Oral Vaccines Market Facts & Figures
6.1 North America Oral Vaccines Sales by Company
6.1.1 North America Oral Vaccines Sales by Company (2016-2021)
6.1.2 North America Oral Vaccines Revenue by Company (2016-2021)
6.2 North America Oral Vaccines Sales Breakdown by Type
6.2.1 North America Oral Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Oral Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Oral Vaccines Sales Breakdown by Application
6.3.1 North America Oral Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Oral Vaccines Sales Breakdown by Application (2022-2027)
7 Europe Oral Vaccines Market Facts & Figures
7.1 Europe Oral Vaccines Sales by Company
7.1.1 Europe Oral Vaccines Sales by Company (2016-2021)
7.1.2 Europe Oral Vaccines Revenue by Company (2016-2021)
7.2 Europe Oral Vaccines Sales Breakdown by Type
7.2.1 Europe Oral Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Oral Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Oral Vaccines Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Oral Vaccines Market Facts & Figures
8.1 China Oral Vaccines Sales by Company
8.1.1 China Oral Vaccines Sales by Company (2016-2021)
8.1.2 China Oral Vaccines Revenue by Company (2016-2021)
8.2 China Oral Vaccines Sales Breakdown by Type
8.2.1 China Oral Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Oral Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Oral Vaccines Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Oral Vaccines Market Facts & Figures
9.1 Japan Oral Vaccines Sales by Company
9.1.1 Japan Oral Vaccines Sales by Company (2016-2021)
9.1.2 Japan Oral Vaccines Revenue by Company (2016-2021)
9.2 Japan Oral Vaccines Sales Breakdown by Type
9.2.1 Japan Oral Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Oral Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Oral Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Oral Vaccines Market Facts & Figures
10.1 Southeast Asia Oral Vaccines Sales by Company
10.1.1 Southeast Asia Oral Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Oral Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Oral Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Oral Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Oral Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Oral Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Oral Vaccines Market Facts & Figures
11.1 India Oral Vaccines Sales by Company
11.1.1 India Oral Vaccines Sales by Company (2016-2021)
11.1.2 India Oral Vaccines Revenue by Company (2016-2021)
11.2 India Oral Vaccines Sales Breakdown by Type
11.2.1 India Oral Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Oral Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Oral Vaccines Sales Breakdown by Application
11.3.1 India Oral Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Oral Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Oral Vaccines Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Oral Vaccines Products Offered
12.1.5 Merck Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Oral Vaccines Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Oral Vaccines Products Offered
12.3.5 Sanofi Recent Development
12.4 Lanzhou Institute
12.4.1 Lanzhou Institute Corporation Information
12.4.2 Lanzhou Institute Business Overview
12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lanzhou Institute Oral Vaccines Products Offered
12.4.5 Lanzhou Institute Recent Development
12.5 Serum Institute
12.5.1 Serum Institute Corporation Information
12.5.2 Serum Institute Business Overview
12.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Serum Institute Oral Vaccines Products Offered
12.5.5 Serum Institute Recent Development
12.6 Valneva
12.6.1 Valneva Corporation Information
12.6.2 Valneva Business Overview
12.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Valneva Oral Vaccines Products Offered
12.6.5 Valneva Recent Development
12.7 Shanghai United Cell
12.7.1 Shanghai United Cell Corporation Information
12.7.2 Shanghai United Cell Business Overview
12.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shanghai United Cell Oral Vaccines Products Offered
12.7.5 Shanghai United Cell Recent Development
12.8 Bibcol
12.8.1 Bibcol Corporation Information
12.8.2 Bibcol Business Overview
12.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bibcol Oral Vaccines Products Offered
12.8.5 Bibcol Recent Development
12.9 PaxVax
12.9.1 PaxVax Corporation Information
12.9.2 PaxVax Business Overview
12.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 PaxVax Oral Vaccines Products Offered
12.9.5 PaxVax Recent Development
12.10 Vabiotech
12.10.1 Vabiotech Corporation Information
12.10.2 Vabiotech Business Overview
12.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Vabiotech Oral Vaccines Products Offered
12.10.5 Vabiotech Recent Development
12.11 Tiantan Biological
12.11.1 Tiantan Biological Corporation Information
12.11.2 Tiantan Biological Business Overview
12.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Tiantan Biological Oral Vaccines Products Offered
12.11.5 Tiantan Biological Recent Development
12.12 EuBiologics
12.12.1 EuBiologics Corporation Information
12.12.2 EuBiologics Business Overview
12.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 EuBiologics Oral Vaccines Products Offered
12.12.5 EuBiologics Recent Development
12.13 Panacea Biotec Ltd
12.13.1 Panacea Biotec Ltd Corporation Information
12.13.2 Panacea Biotec Ltd Business Overview
12.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Panacea Biotec Ltd Oral Vaccines Products Offered
12.13.5 Panacea Biotec Ltd Recent Development
12.14 Bio-Med
12.14.1 Bio-Med Corporation Information
12.14.2 Bio-Med Business Overview
12.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Bio-Med Oral Vaccines Products Offered
12.14.5 Bio-Med Recent Development
12.15 Halfkin Bio-Pharmaceuticals
12.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
12.15.2 Halfkin Bio-Pharmaceuticals Business Overview
12.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Products Offered
12.15.5 Halfkin Bio-Pharmaceuticals Recent Development
13 Oral Vaccines Manufacturing Cost Analysis
13.1 Oral Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oral Vaccines
13.4 Oral Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oral Vaccines Distributors List
14.3 Oral Vaccines Customers
15 Market Dynamics
15.1 Oral Vaccines Market Trends
15.2 Oral Vaccines Drivers
15.3 Oral Vaccines Market Challenges
15.4 Oral Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Oral Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Oral Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Oral Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Oral Vaccines Sales (M Doses) by Region (2016-2021)
Table 5. Global Oral Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Oral Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Oral Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Oral Vaccines Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Oral Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Oral Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Oral Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Oral Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Oral Vaccines Sales Share by Company (2016-2021)
Table 14. Global Oral Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Oral Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Oral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccines as of 2020)
Table 17. Global Oral Vaccines Average Price (USD/K Doses) of Key Company (2016-2021)
Table 18. Manufacturers Oral Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Oral Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Oral Vaccines Sales (M Doses) by Type (2016-2021)
Table 22. Global Oral Vaccines Sales Share by Type (2016-2021)
Table 23. Global Oral Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Oral Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 25. Global Oral Vaccines Sales Share by Type (2022-2027)
Table 26. Global Oral Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Oral Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Oral Vaccines Price (USD/K Doses) by Type (2022-2027)
Table 29. Global Oral Vaccines Sales (M Doses) by Application (2016-2021)
Table 30. Global Oral Vaccines Sales Share by Application (2016-2021)
Table 31. Global Oral Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Oral Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 33. Global Oral Vaccines Sales (M Doses) by Application (2022-2027)
Table 34. Global Oral Vaccines Sales Share by Application (2022-2027)
Table 35. Global Oral Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Oral Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Oral Vaccines Price (USD/K Doses) by Application (2022-2027)
Table 38. North America Oral Vaccines Sales (M Doses) by Company (2016-2021)
Table 39. North America Oral Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Oral Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Oral Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 43. North America Oral Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Oral Vaccines Sales by Type (2022-2027) & (M Doses)
Table 45. North America Oral Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 47. North America Oral Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Oral Vaccines Sales by Application (2022-2027) & (M Doses)
Table 49. North America Oral Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Oral Vaccines Sales (M Doses) by Company (2016-2021)
Table 51. Europe Oral Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Oral Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Oral Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Oral Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Oral Vaccines Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Oral Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Oral Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Oral Vaccines Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Oral Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Oral Vaccines Sales (M Doses) by Company (2016-2021)
Table 63. China Oral Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Oral Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Oral Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 67. China Oral Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Oral Vaccines Sales by Type (2022-2027) & (M Doses)
Table 69. China Oral Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 71. China Oral Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Oral Vaccines Sales by Application (2022-2027) & (M Doses)
Table 73. China Oral Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Oral Vaccines Sales (M Doses) by Company (2016-2021)
Table 75. Japan Oral Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Oral Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Oral Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Oral Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Oral Vaccines Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Oral Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Oral Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Oral Vaccines Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Oral Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Oral Vaccines Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Oral Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Oral Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Oral Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Oral Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Oral Vaccines Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Oral Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Oral Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Oral Vaccines Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Oral Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Oral Vaccines Sales (M Doses) by Company (2016-2021)
Table 99. India Oral Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Oral Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Oral Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 103. India Oral Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Oral Vaccines Sales by Type (2022-2027) & (M Doses)
Table 105. India Oral Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 107. India Oral Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Oral Vaccines Sales by Application (2022-2027) & (M Doses)
Table 109. India Oral Vaccines Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 113. Merck Oral Vaccines Product
Table 114. Merck Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 118. GSK Oral Vaccines Product
Table 119. GSK Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 123. Sanofi Oral Vaccines Product
Table 124. Sanofi Recent Development
Table 125. Lanzhou Institute Corporation Information
Table 126. Lanzhou Institute Description and Business Overview
Table 127. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 128. Lanzhou Institute Oral Vaccines Product
Table 129. Lanzhou Institute Recent Development
Table 130. Serum Institute Corporation Information
Table 131. Serum Institute Description and Business Overview
Table 132. Serum Institute Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 133. Serum Institute Oral Vaccines Product
Table 134. Serum Institute Recent Development
Table 135. Valneva Corporation Information
Table 136. Valneva Description and Business Overview
Table 137. Valneva Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 138. Valneva Oral Vaccines Product
Table 139. Valneva Recent Development
Table 140. Shanghai United Cell Corporation Information
Table 141. Shanghai United Cell Description and Business Overview
Table 142. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 143. Shanghai United Cell Oral Vaccines Product
Table 144. Shanghai United Cell Recent Development
Table 145. Bibcol Corporation Information
Table 146. Bibcol Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 147. Bibcol Description and Business Overview
Table 148. Bibcol Oral Vaccines Product
Table 149. Bibcol Recent Development
Table 150. PaxVax Corporation Information
Table 151. PaxVax Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 152. PaxVax Description and Business Overview
Table 153. PaxVax Oral Vaccines Product
Table 154. PaxVax Recent Development
Table 155. Vabiotech Corporation Information
Table 156. Vabiotech Description and Business Overview
Table 157. Vabiotech Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 158. Vabiotech Oral Vaccines Product
Table 159. Vabiotech Recent Development
Table 160. Tiantan Biological Corporation Information
Table 161. Tiantan Biological Description and Business Overview
Table 162. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 163. Tiantan Biological Oral Vaccines Product
Table 164. Tiantan Biological Recent Development
Table 165. EuBiologics Corporation Information
Table 166. EuBiologics Description and Business Overview
Table 167. EuBiologics Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 168. EuBiologics Oral Vaccines Product
Table 169. EuBiologics Recent Development
Table 170. Panacea Biotec Ltd Corporation Information
Table 171. Panacea Biotec Ltd Description and Business Overview
Table 172. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 173. Panacea Biotec Ltd Oral Vaccines Product
Table 174. Panacea Biotec Ltd Recent Development
Table 175. Bio-Med Corporation Information
Table 176. Bio-Med Description and Business Overview
Table 177. Bio-Med Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 178. Bio-Med Oral Vaccines Product
Table 179. Bio-Med Recent Development
Table 180. Halfkin Bio-Pharmaceuticals Corporation Information
Table 181. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 182. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 183. Halfkin Bio-Pharmaceuticals Oral Vaccines Product
Table 184. Halfkin Bio-Pharmaceuticals Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Oral Vaccines Distributors List
Table 188. Oral Vaccines Customers List
Table 189. Oral Vaccines Market Trends
Table 190. Oral Vaccines Market Drivers
Table 191. Oral Vaccines Market Challenges
Table 192. Oral Vaccines Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oral Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. Public Examples
Figure 7. Private Examples
Figure 8. Global Oral Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Oral Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Oral Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 11. Global Oral Vaccines Price Trends Growth Rate (2016-2027) (USD/K Doses)
Figure 12. Global Oral Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Oral Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Oral Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Oral Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 16. Europe Oral Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Oral Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Oral Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Oral Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Oral Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Oral Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Oral Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Oral Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Oral Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Oral Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Oral Vaccines Players Market Share by Revenue in Oral Vaccines: 2016 & 2020
Figure 27. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Oral Vaccines Revenue Share by Type (2016-2021)
Figure 29. Global Oral Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Oral Vaccines Revenue Share by Application (2016-2021)
Figure 31. Global Oral Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Oral Vaccines Sales Market Share by Type in 2020
Figure 33. North America Oral Vaccines Sales Market Share by Application in 2020
Figure 34. Europe Oral Vaccines Sales Market Share by Type in 2020
Figure 35. Europe Oral Vaccines Sales Market Share by Application in 2020
Figure 36. China Oral Vaccines Sales Market Share by Type in 2020
Figure 37. China Oral Vaccines Sales Market Share by Application in 2020
Figure 38. Japan Oral Vaccines Sales Market Share by Type in 2020
Figure 39. Japan Oral Vaccines Sales Market Share by Application in 2020
Figure 40. Southeast Asia Oral Vaccines Sales Market Share by Type in 2020
Figure 41. Southeast Asia Oral Vaccines Sales Market Share by Application in 2020
Figure 42. India Oral Vaccines Sales Market Share by Type in 2020
Figure 43. India Oral Vaccines Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Oral Vaccines
Figure 46. Manufacturing Process Analysis of Oral Vaccines
Figure 47. Oral Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
経口生コレラワクチンのグローバル市場調査 2019年 The global Oral Live Cholera Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Oral Live Cholera Vaccines volume and value at global level, regional level and company level. From a global per…- コレラワクチンオーラルライブのグローバル市場調査 2019年 The global Cholera Vaccines Oral Live market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cholera Vaccines Oral Live volume and value at global level, regional level and company level. From a global per…
- 世界の治療用タンパク質＆経口ワクチン市場規模・現状・予測（2021年-2027年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There …
- コレラワクチン（経口）のグローバル市場調査 2019年 The global Cholera Vaccine (Oral Route) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cholera Vaccine (Oral Route) volume and value at global level, regional level and company level. From a global…
- ポリオ（灰白髄炎）ワクチンのグローバル市場調査 2019年 The global Polio (Poliomyelitis) Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polio (Poliomyelitis) Vaccines volume and value at global level, regional level and company level. From a gl…